Literature DB >> 18184677

Pulmonary intestinal-type adenocarcinoma.

Ryo Maeda1, Noritaka Isowa, Hideyuki Onuma, Hiroshi Miura.   

Abstract

We report a rare case of pulmonary intestinal-type adenocarcinoma in a 69-year-old man. A computed tomographic scan of the chest and positron emission tomography revealed a well-defined nodule measuring 2.5 cmx2.5 cm in the right lower lobe with high (18)F-fluorodeoxyglucose accumulation. Furthermore, sputum cytology tested positive for adenocarcinoma. Right lower lobectomy and systemic lymph node dissection were performed by video-assisted thoracic surgery (VATS). Histopathologically, the tumor was composed mainly of tall columnar cells with similarity to intestinal epithelia and colorectal carcinoma. Immunohistochemical staining was positive for cytokeratin 7 (CK7) and thyroid transcription factor-1 (TTF-1), whereas staining for cytokeratin 20 (CK20) was negative. The final diagnosis was primary pulmonary intestinal-type adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18184677     DOI: 10.1510/icvts.2007.168716

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  10 in total

1.  Pulmonary enteric adenocarcinoma with pancreatic metastasis: A case report.

Authors:  Wen-Wen Sun; Zhi-Hong Xu; Chao-Fu Wang; Fang Wu; Jiu-Mei Cao; Pei-Jing Cui; Wei Huang; Xiao-Long Jin; Biao Li; Ke-Min Chen; Bei-Li Gao; Jia-An Hu
Journal:  Oncol Lett       Date:  2017-04-20       Impact factor: 2.967

2.  Pulmonary enteric adenocarcinoma.

Authors:  Yoshinori Handa; Yuichiro Kai; Takuhiro Ikeda; Hidenori Mukaida; Hiromi Egawa; Mayumi Kaneko
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-07-03

3.  Combination of Pembrolizumab With Platinum-containing Chemotherapy for Pulmonary Enteric Adenocarcinoma.

Authors:  Shuhei Teranishi; Chihiro Sugimoto; Hirokazu Nagayama; Wataru Segawa; Atsushi Miyasaka; Shuntaro Hiro; Chihiro Maeda; Hironori Tamura; Nami Masumoto; Yoshinori Nagahara; Nobuyuki Hirama; Nobuaki Kobayashi; Masaki Yamamoto; Makoto Kudo; Takeshi Kaneko
Journal:  Cancer Diagn Progn       Date:  2022-03-03

4.  Pulmonary enteric adenocarcinoma with villin brush border immunoreactivity: a case report and literature review.

Authors:  Dongliang Lin; Yonggang Zhao; Hong Li; Xiaoming Xing
Journal:  J Thorac Dis       Date:  2013-02       Impact factor: 2.895

5.  Clinicopathological observation of primary lung enteric adenocarcinoma and its response to chemotherapy: A case report and review of the literature.

Authors:  L I Lin; Chun-Wei Xu; B O Zhang; Rong-Rui Liu; Fei-Jiao Ge; Chuan-Hua Zhao; R U Jia; Quan-Hong Qin; Jelena Stojsic; Yan Wang; Jian-Ming Xu
Journal:  Exp Ther Med       Date:  2015-11-12       Impact factor: 2.447

6.  Pulmonary enteric adenocarcinoma: a study of the clinicopathologic and molecular status of nine cases.

Authors:  Cai-Xia Wang; Biao Liu; Yan-Fen Wang; Ru-Song Zhang; Bo Yu; Zhen-Feng Lu; Qun-Li Shi; Xiao-Jun Zhou
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15

7.  Intestinal type of lung adenocarcinoma in younger adults.

Authors:  Jelena Stojsic; Milica Kontic; Dragan Subotic; Marko Popovic; Dragana Tomasevic; Jelena Lukic
Journal:  Case Rep Pulmonol       Date:  2014-03-23

8.  Primary pulmonary adenocarcinoma mimicking papillary thyroid carcinoma.

Authors:  Ya-Zhen Zhu; Wei-Ping Li; Zhi-Yuan Wang; Hai-Feng Yang; Qing-Lian He; Hong-Guang Zhu; Guang-Juan Zheng
Journal:  J Cardiothorac Surg       Date:  2013-05-17       Impact factor: 1.637

9.  MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy.

Authors:  Guido Biasco; Elisa Giovannetti; Ingrid Garajová; Niccola Funel; Michelangelo Fiorentino; Valentina Agostini; Manuela Ferracin; Massimo Negrini; Giovanni Luca Frassineti; Giampaolo Gavelli; Adam Enver Frampton
Journal:  Clin Epigenetics       Date:  2015-12-16       Impact factor: 6.551

10.  Distinctive features of immunostaining and mutational load in primary pulmonary enteric adenocarcinoma: implications for differential diagnosis and immunotherapy.

Authors:  Ming Chen; Pu Liu; Feifei Yan; Suzhen Xu; Qi Jiang; Jingying Pan; Mengye He; Peng Shen
Journal:  J Transl Med       Date:  2018-03-27       Impact factor: 5.531

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.